The research was conducted within the Environmental influences on Child Health Outcomes program, a large federally funded initiative that pools data from multiple pregnancy and birth cohorts across the United States. The ECHO.CA.IL cohorts analyzed here represent geographically and demographically diverse populations, allowing researchers to examine exposure-outcome relationships with a breadth that single-site studies rarely achieve. Because developmental outcomes in infancy are shaped by an intricate web of genetic, social, and environmental factors, the scale and diversity of the cohort framework are essential for isolating signals that might otherwise be attributed to confounding influences.

Aromatic amines enter the human body through several well-characterized routes. They can migrate from colored textiles and food packaging into foodstuffs, particularly under heat, and they have been detected in tobacco smoke, diesel exhaust, hair dyes, and contaminated drinking water. Biomonitoring studies conducted over the past decade have found metabolites of these compounds in the urine of a large proportion of the general population, including pregnant women, which means that the developing fetus can be exposed through the placenta. Some aromatic amines, such as aniline and its derivatives, are classified or flagged as potential carcinogens in occupational settings, but their effects on the developing brain at everyday environmental levels have remained largely unexplored until recently.

To quantify prenatal exposure, the research team measured urinary concentrations of aromatic amine metabolites in samples collected from participants during pregnancy. Urinary biomarkers offer a window into recent integrated exposure and are considered one of the most practical tools for assessing contact with these chemicals in non-occupational settings. By combining laboratory measurements with questionnaire data on demographics, lifestyle, and environmental factors, the investigators were able to model the relationship between exposure levels and later infant outcomes while accounting for a range of potential confounders, including maternal education, household income, gestational age at birth, and infant sex.

Cognitive development in the infants was assessed using standardized developmental screening instruments administered during the first two years of life. These tools evaluate domains such as fine motor skills, expressive and receptive communication, problem-solving, and personal-social behavior. Rather than diagnosing disorders, such assessments generate continuous scores that capture subtle variation across a population. This approach is particularly valuable in environmental epidemiology, where the effects of low-level chemical exposure are expected to be modest shifts in the distribution of ability rather than dramatic impairments in individual children.

The central analytical question was whether higher concentrations of aromatic amine metabolites during pregnancy were associated with lower cognitive or developmental scores in infancy. Studies of this design must contend with the challenge that chemical exposures do not occur in isolation. Pregnant women exposed to aromatic amines are often simultaneously exposed to phthalates, bisphenols, flame retardants, and air pollutants, many of which share sources such as plastics, processed foods, and urban environments. The researchers therefore employed statistical adjustments and sensitivity analyses to test whether the observed associations could plausibly be attributed to aromatic amines themselves rather than to correlated co-exposures or residual confounding.

The broader significance of the work lies in what it reveals about the hidden chemistry of modern pregnancy. Aromatic amines have historically been studied almost exclusively in industrial hygiene contexts, where workers exposed to high concentrations faced well-documented risks of bladder cancer. The shift in focus toward population-level, low-dose exposure reflects a growing recognition that developmental windows of vulnerability, particularly the prenatal period, may be sensitive to chemical signals that produce no overt toxicity in adults. The fetal brain undergoes extraordinary waves of neuronal proliferation, migration, and synapse formation during gestation, and endocrine-active or neurotoxic compounds that perturb these processes can leave lasting developmental traces even at concentrations considered harmless by older toxicological benchmarks.

The findings also contribute to a rapidly expanding body of literature on the developmental origins of health and disease. This framework holds that conditions experienced in utero, ranging from maternal nutrition and stress to chemical exposures, program long-term trajectories of physical and cognitive health. Within this paradigm, even small shifts in population-level developmental scores can carry public health weight, because they indicate that a common environmental exposure is measurably interacting with the earliest stages of human neurodevelopment. When a chemical is detectable in the majority of pregnant women, as urinary biomonitoring suggests for several aromatic amines, a modest population-level effect translates into a meaningful burden at the societal scale.

For families, the practical question is what can be done to reduce exposure while the science matures. Aromatic amines can be released from intensely colored foods, dyed fabrics, rubber items, and some personal care products, and they are also present in secondhand smoke and vehicle exhaust. While individual avoidance is complicated by the ubiquity of these compounds, evidence-based strategies include minimizing contact with tobacco smoke, choosing fragrance-free and dye-minimal products where feasible, reducing the use of heavily dyed or rubberized items in food preparation, and supporting policies that restrict hazardous dye intermediates in consumer goods. Regulatory attention to aromatic amines has focused primarily on dye manufacturing and food contact materials in Europe, and studies of this kind strengthen the case for broader surveillance in North America.

The ECHO program’s cohort approach will continue to follow these children as they grow, offering the possibility of determining whether early-life associations with prenatal aromatic amines persist, attenuate, or amplify across childhood. Longitudinal extension is critical, because infant screening scores are imperfect predictors of later cognition and because developmental trajectories are shaped by compensatory environments after birth. In the meantime, the study adds an important and previously underappreciated class of chemicals to the list of prenatal exposures that clinicians, regulators, and researchers should monitor. As biomonitoring technology improves and cohort data accumulate, the scientific community moves closer to a complete map of the chemical landscape that accompanies every human pregnancy, and to evidence-based guidance for protecting the developing brain within it.

Subject of Research: Associations between prenatal exposure to aromatic amines and infant cognitive development in the ECHO.CA.IL cohorts

Article Title: Prenatal exposure to aromatic amines and associations with infant cognition in the ECHO.CA.IL cohorts

Article References: Eick, S. M., Ortlund, K., Padula, A. M., Kannan, K., Aguiar, A., Robinson, J. F., Morello-Frosch, R., Schantz, S. L., & Woodruff, T. J. (2026). Prenatal exposure to aromatic amines and associations with infant cognition in the ECHO.CA.IL cohorts. Journal of Exposure Science & Environmental Epidemiology. https://doi.org/10.1038/s41370-026-00905-3

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00905-3

Keywords: aromatic amines, prenatal exposure, infant cognition, ECHO program, environmental epidemiology, neurodevelopment, biomonitoring, developmental toxicology, pregnancy, chemical exposure, public health, cohorts